Triple I for Global Health

About Triple I

Invest in Global Health. Make an Impact.

Impact Investment Initiative for Global Health (Triple I for Global Health) was endorsed at the G7 Hiroshima Summit 2023.

We aim to build up a wider partnership to realize the world in which everyone, regardless of age, gender, or place of residence — particularly in low- and middle-income countries (LMICs) — has access to essential healthcare services and the supporting health systems.

Triple I for Global Health was launched at the United Nations General Assembly High-Level Meetings in September 2023. By ensuring that everyone, particularly the most vulnerable people, has access to quality health services without experiencing financial hardship, we strive to create more equitable and sustainable health systems worldwide.

G7 HIROSHIMA SUMMIT 2023

What We Aim For

Triple I for Global Health builds partnerships. Our partners include private investors, financial institutions, foundations, philanthropic organizations, civil society, academia, governments, and public development banks.

Within this partnership network, each actor plays a distinct but complementary role. These roles include increasing financial flow into health provisions, developing more effective health solutions, ensuring that the most vulnerable groups have a voice in policy-making and decision-making, and safeguarding delivery by aligning policies, regulations, and implementation efforts.

Triple I for Global Health partnership diagram

Who We Are

Triple I for Global Health is led by three co-chairs and works closely with Advisory & Advocacy (AA Partners) and Implementation/Knowledge (IK Partners) partners and Advisory Committee members along with partners from different sectors, with the number of partners continuing to grow since its establishment. The Secretariat has been run by the Cabinet Secretariat, Government of Japan since its inception.

  • Mr. Ken Shibusawa

    Mr. Ken Shibusawa

    CEO, Shibusawa & Company, Inc.
    CEO and Founder, &Capital Inc.
    Chairman, Commons Asset Management
    Member of the Council on "The New Form of Capitalism"
    GSG Japan NAB Chair

    Mr. Ken Shibusawa
    Mr. Ken Shibusawa
    CEO, Shibusawa & Company, Inc.
    CEO and Founder, &Capital Inc.
    Chairman, Commons Asset Management
    Member of the Council on “The New Form of Capitalism”
    GSG Japan NAB Chair

    Ken Shibusawa founded in 2001, Shibusawa and Company, Inc., and in 2008, Commons Asset Management. In 2021, he joined Brunswick Group as senior advisor.
    He has extensive market experience at JP Morgan, Goldman Sachs, and Moore Capital, a global macro hedge fund, where he was the representative managing director of the Tokyo Office. He is also co-chair of Global South-Africa Committee at Keizai Doyukai (Japan Association of Corporate Executives), advisor to the Office of the President at the University of Tokyo, member of various government panels, including Prime Minister Kishida’s Council on New Capitalism, and a steering group member of UNDP SDG Impact.
    In 2022, he was named as board member of the newly founded International Foundation for Valuing Impact, as special advisor to the ISSB (International Sustainability Standards Boards) chair. In 2023, he founded &Capital, Inc., an impact fund management company for Africa.

  • Dr. Ayoade Alakija

    Dr. Ayoade Alakija

    The board chair of FIND,
    the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

    Dr. Ayoade Alakija
    Dr. Ayoade Alakija
    The board chair of FIND,
    the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

    Dr. Ayoade Alakija is a renowned global health leader with expertise in pandemic preparedness and health security and diplomacy. With over two decades in the field, her dedication to equitable access became especially pronounced during COVID-19. As FIND’s board chair and the WHO Special Envoy for the ACT-Accelerator, she focuses on creating transformative impacts, particularly for the Global South.

    In her role as Nigeria’s Chief Humanitarian Coordinator, she adeptly managed responses to humanitarian crises, and steered the Oslo Humanitarian Conference for Nigeria and the Lake Chad region. As the Chair of the African Vaccine Delivery Alliance, she has been pivotal in championing Africa’s voice for access to medical countermeasures.

    Dr. Alakija is a staunch advocate for women’s equity, believing in investing in women not just as a gender initiative but as a profitable business decision. Her voice consistently champions justice, echoing both in influential boardrooms and at the grassroots level.

  • Mr. Steve Davis

    Mr. Steve Davis

    Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Gates Foundation.
    Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
    Member of the Council on Foreign Relations

    Mr. Steve Davis
    Mr. Steve Davis
    Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Gates Foundation.
    Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
    Member of the Council on Foreign Relations

    Steve Davis serves as a Senior Advisor and Interim Director of the Philanthropic Partnerships Team at Bill & Melinda Gates Foundation, as a Lecturer at the Stanford Graduate School of Business, and as a member of the Council on Foreign Relations. Steve has deep experience, and sits on numerous boards and advisory groups, focused on the intersection of business, innovation, and social impact. He most recently served as Senior Advisor for McKinsey & Company. Before that, he was Executive Strategic Advisor and Interim Director, China Country Office, for the Bill & Melinda Gates Foundation, co-chair of the World Health Organization’s Digital Health Technical Advisory Group, and Distinguished Fellow for the World Economic Forum. Steve is also the former President & CEO of PATH, a leading global health innovation organization; former Director of Social Innovation at McKinsey; former CEO of Corbis, a digital media pioneer; and as an attorney with K&L Gates. With degrees from Princeton University, University of Washington, and Columbia Law School, Steve also is the author of Undercurrents: Channeling Outrage to Spark Practical Activism (Wiley 2020), and speaks and writes frequently on topics related to corporate engagement in social impact, social innovation, and digital health. He lives with his family in Seattle, Washington.

AA Partners

Advisory & Advocacy

  • The Center for Global Health and Development
  • G20 & G7 Health & Development Partnership
  • Global Health Investment Corporation
  • Global Health Technologies Coalition
  • Global Private Capital Association
  • Health Innovation Exchange
  • UHC2030

IK Partners

Implementation / Knowledge

  • Gates Foundation
  • GSG
  • GIIN
  • Impact Taskforce

*AA Partners are dedicated to supporting and advising on the promotion and expansion of impact investing in global health.

*IK Partners provide the expertise and experience necessary for the practice of impact investing.

Secretariat

Cabinet Secretariat, Government of Japan

Thank you for visiting us.
In order to provide better usage of this website and improve our services, we ask that you consent to the acquisition and use of cookies based on our policy.

About cookies